These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 11043659)
1. Detection of cannabis in oral fluid (saliva) and forehead wipes (sweat) from impaired drivers. Kintz P; Cirimele V; Ludes B J Anal Toxicol; 2000 Oct; 24(7):557-61. PubMed ID: 11043659 [TBL] [Abstract][Full Text] [Related]
2. Detection of cannabis use in drivers with the drugwipe device and by GC-MS after Intercept device collection. Kintz P; Bernhard W; Villain M; Gasser M; Aebi B; Cirimele V J Anal Toxicol; 2005 Oct; 29(7):724-7. PubMed ID: 16419408 [TBL] [Abstract][Full Text] [Related]
3. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence. Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094 [TBL] [Abstract][Full Text] [Related]
4. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389 [TBL] [Abstract][Full Text] [Related]
5. Oral fluid testing for cannabis: on-site OraLine IV s.a.t. device versus GC/MS. Cirimele V; Villain M; Mura P; Bernard M; Kintz P Forensic Sci Int; 2006 Sep; 161(2-3):180-4. PubMed ID: 16854544 [TBL] [Abstract][Full Text] [Related]
6. Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration. Milman G; Barnes AJ; Schwope DM; Schwilke EW; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA Anal Bioanal Chem; 2011 Aug; 401(2):599-607. PubMed ID: 21637933 [TBL] [Abstract][Full Text] [Related]
7. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers. Samyn N; De Boeck G; Verstraete AG J Forensic Sci; 2002 Nov; 47(6):1380-7. PubMed ID: 12455668 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Cozart DDSV test for cannabis in oral fluid. Kintz P; Brunet B; Muller JF; Serra W; Villain M; Cirimele V; Mura P Ther Drug Monit; 2009 Feb; 31(1):131-4. PubMed ID: 19155965 [TBL] [Abstract][Full Text] [Related]
9. Comparison between self-report of cannabis use and toxicological detection of THC/THCCOOH in blood and THC in oral fluid in drivers in a roadside survey. Van der Linden T; Silverans P; Verstraete AG Drug Test Anal; 2014; 6(1-2):137-42. PubMed ID: 23939912 [TBL] [Abstract][Full Text] [Related]
10. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. Niedbala RS; Kardos KW; Fritch DF; Kardos S; Fries T; Waga J; Robb J; Cone EJ J Anal Toxicol; 2001; 25(5):289-303. PubMed ID: 11499881 [TBL] [Abstract][Full Text] [Related]
11. Cannabis Use Surveillance by Sweat Analysis. Gambelunghe C; Fucci N; Aroni K; Bacci M; Marcelli A; Rossi R Ther Drug Monit; 2016 Oct; 38(5):634-9. PubMed ID: 27465974 [TBL] [Abstract][Full Text] [Related]
13. Driving under the influence of cannabis: pitfalls, validation, and quality control of a UPLC-MS/MS method for the quantification of tetrahydrocannabinol in oral fluid collected with StatSure, Quantisal, or Certus collector. Wille SM; Di Fazio V; Ramírez-Fernandez Mdel M; Kummer N; Samyn N Ther Drug Monit; 2013 Feb; 35(1):101-11. PubMed ID: 23318281 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users. Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449 [TBL] [Abstract][Full Text] [Related]
15. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. Huestis MA; Cone EJ J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285 [TBL] [Abstract][Full Text] [Related]
16. Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays. Moore C; Ross W; Coulter C; Adams L; Rana S; Vincent M; Soares J J Anal Toxicol; 2006 Sep; 30(7):413-8. PubMed ID: 16959132 [TBL] [Abstract][Full Text] [Related]
17. Fluorescence-based lateral flow assays for rapid oral fluid roadside detection of cannabis use. Plouffe BD; Murthy SK Electrophoresis; 2017 Feb; 38(3-4):501-506. PubMed ID: 27862053 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults. Schlienz NJ; Cone EJ; Herrmann ES; Lembeck NA; Mitchell JM; Bigelow GE; Flegel R; LoDico CP; Hayes ED; Vandrey R J Anal Toxicol; 2018 May; 42(4):232-247. PubMed ID: 29300962 [TBL] [Abstract][Full Text] [Related]
19. Validation of an enzyme immunoassay for detection and semiquantification of cannabinoids in oral fluid. Schwope DM; Milman G; Huestis MA Clin Chem; 2010 Jun; 56(6):1007-14. PubMed ID: 20360126 [TBL] [Abstract][Full Text] [Related]
20. Influence of ethanol on the pharmacokinetic properties of Δ9-tetrahydrocannabinol in oral fluid. Toennes SW; Schneider K; Wunder C; Kauert GF; Moeller MR; Theunissen EL; Ramaekers JG J Anal Toxicol; 2013 Apr; 37(3):152-8. PubMed ID: 23429905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]